Nymox Pharmaceutical Corporation

Nymox Pharmaceutical Corporation

Nymox pharmaceutical Corporation is a biopharmaceutical company
with three unique proprietary products on the market and a
significant R&D pipeline of drug products in development in the
areas of Alzheimer's disease, benign prostatic hyperplasia and
E. coli O157:H7 contamination.

Company Details

Year Established: 1995

Company Information

Roy Wolvin
Title: Chief Financial Officer
Area of Responsibility: Finance/Accounting
Telephone: (514) 332-3222
Fax: (514) 332-2227
Email: Click Here

Michael Munzar
Title: Director
Area of Responsibility: Research/Development/Engineering
Telephone: (514) 332-3222
Fax: (514) 332-2227

Products

Nicalert (tm)

Tobacalert (tm)
TobacAlert (TM) is a point-of-care test that is so accurate it can measure second hand smoke exposure. It tests for Cotinine (a Nicotine metabolite) in urine.

Services

Alzheimalert (tm) AlzheimAlert(TM) is a urinary test that can assist the physicican in the diagnosis of Alzheimer's disease. AlzheimAlert(TM) measures neural thread protein which is elevated early in Alzheimer's disease. AlzheimAlert(TM) in urine is 80 - 85% sensitive, and over 90% specific.